No abstract available
MeSH terms
-
Antineoplastic Agents / pharmacology*
-
Carcinoma, Non-Small-Cell Lung / drug therapy*
-
Cisplatin / administration & dosage
-
Cisplatin / pharmacology
-
Clinical Trials, Phase III as Topic
-
Epidermal Growth Factor / antagonists & inhibitors
-
Gefitinib
-
Humans
-
Lung Neoplasms / drug therapy*
-
Protein-Tyrosine Kinases / antagonists & inhibitors
-
Quality of Life
-
Quinazolines / pharmacology*
-
Survival Analysis
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Quinazolines
-
Epidermal Growth Factor
-
Protein-Tyrosine Kinases
-
Cisplatin
-
Gefitinib